At InnoLan, Ltd UK, we are committed to advancing global animal health through cutting-edge solutions in pathogen diagnostics, vaccine development, and biologics innovation. Our interdisciplinary team of scientists, veterinarians, and technologists work at the intersection of microbiology, biotechnology, and data science to tackle some of the world’s most pressing infectious disease challenges in animals.

With a strong foundation in molecular biology and immunology, we develop high-sensitivity diagnostic platforms for rapid and accurate pathogen detection — enabling early intervention, containment, and treatment. Our diagnostic tools are designed to meet the needs of veterinary labs, veterinary health systems, and field-based environments.

In our vaccine development programs, we leverage state-of-the-art platforms including recombinant proteins, and viral vectors to create next-generation vaccines that are both safe and effective. We target emerging and re-emerging infectious diseases with huge economica impacts, striving to stay ahead of microbial threats.

Our biologics division focuses on the research and production of therapeutic proteins, disinfectants, feed adatives and suppliments that support both preventive and therapeutic interventions. From discovery to field application, we aim to bring biologics to patients faster and more affordably.

Driven by innovation, guided by science, and grounded in impact — we envision a future where infectious diseases are rapidly identified, effectively treated, and ultimately prevented.

Join us in shaping a healthier world through scientific excellence and transformative healthcare solutions.